JPY 781.0
(-1.14%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.38 Billion JPY | 363.21% |
2022 | 299 Million JPY | -59.97% |
2021 | 747 Million JPY | 16.72% |
2020 | 640 Million JPY | -21.95% |
2019 | 820 Million JPY | 90.7% |
2018 | 430 Million JPY | -44.01% |
2017 | 768 Million JPY | -41.73% |
2016 | 1.31 Billion JPY | 26.12% |
2015 | 1.04 Billion JPY | 48.17% |
2014 | 705.28 Million JPY | -30.55% |
2013 | 1.01 Billion JPY | -13.43% |
2012 | 1.17 Billion JPY | 7.25% |
2011 | 1.09 Billion JPY | 0.0% |
2010 | - JPY | -100.0% |
2009 | 794.53 Million JPY | 223.78% |
2008 | 245.39 Million JPY | -64.56% |
2007 | 692.35 Million JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 230 Million JPY | -50.32% |
2023 FY | 1.38 Billion JPY | 363.21% |
2023 Q3 | 240 Million JPY | -47.14% |
2023 Q2 | 454 Million JPY | 100.0% |
2023 Q4 | 463 Million JPY | 92.92% |
2023 Q1 | 227 Million JPY | 653.66% |
2022 Q1 | 72 Million JPY | -78.7% |
2022 FY | 299 Million JPY | -59.97% |
2022 Q4 | -41 Million JPY | -783.33% |
2022 Q3 | 6 Million JPY | -97.71% |
2022 Q2 | 262 Million JPY | 263.89% |
2021 Q4 | 338 Million JPY | 136.36% |
2021 Q1 | 59 Million JPY | -77.22% |
2021 Q2 | 207 Million JPY | 250.85% |
2021 Q3 | 143 Million JPY | -30.92% |
2021 FY | 747 Million JPY | 16.72% |
2020 Q1 | 119 Million JPY | -50.83% |
2020 Q2 | 142 Million JPY | 19.33% |
2020 Q3 | 120 Million JPY | -15.49% |
2020 Q4 | 259 Million JPY | 115.83% |
2020 FY | 640 Million JPY | -21.95% |
2019 Q1 | -5 Million JPY | -106.76% |
2019 FY | 820 Million JPY | 90.7% |
2019 Q4 | 242 Million JPY | -45.0% |
2019 Q3 | 440 Million JPY | 207.69% |
2019 Q2 | 143 Million JPY | 2960.0% |
2018 Q3 | 124 Million JPY | 16.98% |
2018 Q2 | 106 Million JPY | -15.87% |
2018 Q1 | 126 Million JPY | -47.06% |
2018 FY | 430 Million JPY | -44.01% |
2018 Q4 | 74 Million JPY | -40.32% |
2017 FY | 768 Million JPY | -41.73% |
2017 Q3 | 326 Million JPY | 171.67% |
2017 Q2 | 120 Million JPY | 42.86% |
2017 Q4 | 238 Million JPY | -26.99% |
2017 Q1 | 84 Million JPY | -59.02% |
2016 Q3 | 297 Million JPY | -30.28% |
2016 Q4 | 205 Million JPY | -30.98% |
2016 FY | 1.31 Billion JPY | 26.12% |
2016 Q1 | 390 Million JPY | 56.0% |
2016 Q2 | 426 Million JPY | 9.23% |
2015 Q2 | 253 Million JPY | -41.3% |
2015 FY | 1.04 Billion JPY | 48.17% |
2015 Q4 | 250 Million JPY | -17.49% |
2015 Q1 | 431 Million JPY | 643.1% |
2015 Q3 | 303 Million JPY | 19.76% |
2014 FY | 705.28 Million JPY | -30.55% |
2014 Q2 | 62.49 Million JPY | -81.47% |
2014 Q1 | 337.32 Million JPY | 191.01% |
2014 Q4 | 58 Million JPY | -69.4% |
2014 Q3 | 189.55 Million JPY | 203.3% |
2013 Q4 | 115.91 Million JPY | -56.6% |
2013 FY | 1.01 Billion JPY | -13.43% |
2013 Q3 | 267.07 Million JPY | 18.08% |
2013 Q2 | 226.17 Million JPY | -39.9% |
2013 Q1 | 376.31 Million JPY | 157.88% |
2012 Q1 | 426.27 Million JPY | 195.98% |
2012 FY | 1.17 Billion JPY | 7.25% |
2012 Q4 | 145.92 Million JPY | -56.56% |
2012 Q3 | 335.91 Million JPY | 25.92% |
2012 Q2 | 266.75 Million JPY | -37.42% |
2011 FY | 1.09 Billion JPY | 0.0% |
2011 Q2 | 209.96 Million JPY | -43.22% |
2011 Q3 | 238.58 Million JPY | 13.63% |
2011 Q4 | 144.02 Million JPY | -39.63% |
2011 Q1 | 369.8 Million JPY | 34.3% |
2010 Q1 | 334.45 Million JPY | 65.7% |
2010 FY | - JPY | -100.0% |
2010 Q4 | 275.35 Million JPY | 0.0% |
2010 Q2 | 200.38 Million JPY | -40.09% |
2009 Q1 | 269.51 Million JPY | 10.12% |
2009 Q2 | 212.77 Million JPY | -21.05% |
2009 Q3 | 67.49 Million JPY | -68.28% |
2009 FY | 794.53 Million JPY | 223.78% |
2009 Q4 | 201.84 Million JPY | 199.05% |
2008 Q3 | -60.57 Million JPY | -582.74% |
2008 Q1 | 238.12 Million JPY | 0.0% |
2008 FY | 245.39 Million JPY | -64.56% |
2008 Q2 | 12.54 Million JPY | -94.73% |
2008 Q4 | 244.74 Million JPY | 504.08% |
2007 FY | 692.35 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
HEARTSEED INC | -1.45 Billion JPY | 194.888% |
Cawachi Limited | 7.6 Billion JPY | 81.779% |
Pharmarise Holdings Corporation | 916 Million JPY | -51.201% |
Qol Holdings Co., Ltd. | 8.32 Billion JPY | 83.363% |
MatsukiyoCocokara & Co. | 75.7 Billion JPY | 98.171% |
Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 96.796% |
Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 93.153% |
NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 84.853% |
COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 95.603% |
Tsuruha Holdings Inc. | 49.2 Billion JPY | 97.185% |
Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | 32.241% |
Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 92.541% |
Medical System Network Co., Ltd. | 3.83 Billion JPY | 63.857% |
Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | 63.106% |
Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 96.218% |
YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | 73.422% |
Astena Holdings Co., Ltd. | 1.12 Billion JPY | -22.774% |
Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 84.638% |
Ain Holdings Inc. | 20.43 Billion JPY | 93.221% |
Sundrug Co.,Ltd. | 40.99 Billion JPY | 96.622% |